Key result
Allograft coronary disease has emerged as a major limitation to long-term heart transplant recipient survival, accounting for the most deaths in patients surviving for more than one year.
Population
Heart transplant recipients
Design
Review
Authors
Loading...
Underscores allograft coronary disease as a key survival barrier post-transplant; leaves open optimal surveillance and therapy strategies.
Allograft coronary disease is a major limitation to long-term survival in heart transplant recipients, presenting significant diagnostic and therapeutic challenges.
Gayle L. Winters (2001) conducted a review in Allograft coronary disease in heart transplant recipients. Allograft coronary disease has emerged as a major limitation to long-term heart transplant recipient survival, accounting for the most deaths in patients surviving for more than one year.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: